| Date Filed | Type | Description |
| 10/03/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 819 shares
@ $0 |
|
| 07/05/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 619 shares
@ $0 |
|
| 06/16/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 1,865 shares
@ $0
Granted 4,661 options to buy
@ $57.62, valued at
$268.6k
|
|
| 05/30/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 6,754 shares
@ $0 |
|
| 04/04/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 435 shares
@ $0 |
|
| 01/04/2023 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 397 shares
@ $0 |
|
| 10/04/2022 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 337 shares
@ $0 |
|
| 09/16/2022 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $11.48, valued at
$114.8k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 190 shares
@ $0 |
|
| 01/04/2022 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 1,500 shares
@ $150.3793, valued at
$225.6k
|
|
| 01/04/2022 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 169 shares
@ $0 |
|
| 11/29/2021 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 1,500 shares
@ $150.0563, valued at
$225.1k
|
|
| 10/27/2021 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 100 shares
@ $163.85, valued at
$16.4k
Sold 600 shares
@ $165.1407, valued at
$99.1k
Sold 400 shares
@ $166.6033, valued at
$66.6k
Sold 100 shares
@ $167.63, valued at
$16.8k
Sold 300 shares
@ $168.68, valued at
$50.6k
|
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/25/2021 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 200 shares
@ $157.715, valued at
$31.5k
Sold 100 shares
@ $160.56, valued at
$16.1k
Sold 500 shares
@ $162.27, valued at
$81.1k
Sold 600 shares
@ $163.2475, valued at
$97.9k
Sold 100 shares
@ $164.05, valued at
$16.4k
|
|
| 07/26/2021 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 459 shares
@ $182.3188, valued at
$83.7k
Sold 400 shares
@ $183.0748, valued at
$73.2k
Sold 400 shares
@ $184.4273, valued at
$73.8k
Sold 241 shares
@ $185.9551, valued at
$44.8k
|
|
| 06/25/2021 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Sold 200 shares
@ $197.26, valued at
$39.5k
Sold 400 shares
@ $199.4, valued at
$79.8k
Sold 500 shares
@ $200.0322, valued at
$100k
Sold 400 shares
@ $201.7377, valued at
$80.7k
|
|
| 06/15/2021 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 625 shares
@ $0
Granted 1,563 options to buy
@ $193.51, valued at
$302.5k
|
|
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Granted 4,432 options to buy
@ $88.42, valued at
$391.9k
|
|
| 06/01/2020 |
4
| Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $11.48, valued at
$114.8k
|
|
| 04/17/2020 |
4
| Kosaraju Sridhar (President) has filed a Form 4 on Penumbra Inc|
Txns:
| Sold 200 shares
@ $164.89, valued at
$33k
Sold 100 shares
@ $166.16, valued at
$16.6k
Sold 300 shares
@ $167.26, valued at
$50.2k
Sold 217 shares
@ $168.41, valued at
$36.5k
Sold 600 shares
@ $169.4, valued at
$101.6k
Sold 383 shares
@ $170.3, valued at
$65.2k
Sold 700 shares
@ $171.46, valued at
$120k
|
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| Kosaraju Sridhar (President) has filed a Form 4 on Penumbra Inc|
Txns:
| Sold 1,200 shares
@ $175.09, valued at
$210.1k
Sold 500 shares
@ $176.01, valued at
$88k
Sold 300 shares
@ $177.4, valued at
$53.2k
Sold 500 shares
@ $178.08, valued at
$89k
|
|
|